Page 29 - World Journal of Laparoscopic Surgery
P. 29

Bariatric Surgery during the COVID-19 Pandemic
               The primary outcome measure was COVID-19-related mortality   COVID-19 swab tests were performed between 24 and 48 hours
            and morbidity at a 6-week follow-up. The secondary outcome   prior to surgery. Results were available within 24 hours. Computed
            measures were non-COVID-19-related morbidity as defined by the   tomography (CT) of the thorax was not routinely performed
                                 8
            Clavien-Dindo classification,  in-hospital mortality, and length of   preoperatively. Patients were informed that there was a slightly
            hospital stay.                                     increased risk of developing COVID-19-related morbidity as part
                                                               of the consent process but no detailed figures on risk were given.
            Standard of Care
                                                          2
            Patients with body mass indices (BMI) greater than 40 kg/m  or   Intraoperative
                      2
            35–39.9 kg/m , with at least one obesity-related comorbidity, were   Based on evolving national and local guidelines, anesthesia and
            offered bariatric surgery following successful completion of a   surgery were performed in amber personal protective equipment
            supervised tier-3 weight management program. A multidisciplinary   (PPE) (visor/goggles, standard surgical masks). A closed filtration
            team that includes a bariatric medical specialist, specialist bariatric   system was used to safely evacuate pneumoperitoneum before
            nurse, dietitian, and surgeon is involved in a comprehensive   trocar removal and closure. 10
            assessment of the patient. Formal psychological assessment is
            undertaken following a routine screening questionnaire. In general,   Postoperative
            patients are given a choice between Roux-en-Y gastric bypass (RYGB)   Patients were nursed in a COVID-19 light ward. Asymptomatic
            and sleeve gastrectomy (SG). RYGB is preferred if patients suffer from   elective patients with a negative COVID-19 swab test who had been
            gastroesophageal reflux disease. SG is usually offered to patients   isolating for 14 days were admitted there. Emergency patients were
                                    2
            with a BMI greater than 60 kg/m . Patients undergo a supervised   only admitted there after 24 hours, in our Surgical Admissions Unit
            low-calorie liver-reducing diet for 3 weeks prior to surgery.  (SAU) in addition to ensuring that they were asymptomatic from
               Our technique of RYGB involves the creation of an approximately   COVID-19 point of view with negative swab tests. COVID-19 swab
            30-mL gastric pouch. The small bowel is divided 50 cm from the   tests were performed if patients developed a temperature.
            ligament of Treitz creating the proximal biliopancreatic limb,
            which is then anastomosed to a 100-cm-long alimentary limb.  results
            The alimentary limb is then advanced to the gastric pouch for an   Demographic and treatment details are listed in Table 1. All patients
            antecolic antegastric end-to-side gastrojejunostomy, which is then   underwent preoperative COVID-19 swab tests. No patients were
            closed with a double-layered 3/0 STRATAFIX™ (Johnson & Johnson).   diagnosed with COVID-19 in the preoperative screening process.
            The SG involves an initial 60-mm green stapler (Powered ECHELON   All patients who were offered surgery agreed to undergo the
            FLEX™ GST System, Johnson & Johnson) with reducing staple height   procedure. Two patients required postoperative COVID-19 swab
            according to tissue thickness over a 34-French orogastric bougie,   test according to hospital testing protocol and had negative results.
            starting at least 3 cm from the pylorus and ending at 2 cm from   All procedures were completed laparoscopically. One patient who
            the gastroesophageal junction. After the gastric mobilization is   developed an anastomotic leak had a re-look laparotomy, lavage,
            completed, 20 mg of hyoscine butylbromide is given intravenously.   and drain placement.
            The systolic blood pressure is reduced to approximately 100 mm Hg   Outcomes are detailed in Table 2. One patient, who underwent
            prior to stapling and then increased to 140 mm Hg after stapling is   a SG re-laparoscopy on day 1 for a staple line bleed, had no active
            completed, to reveal any staple line bleeding. Active bleeding points   bleeding point but a hematoma around the staple line was
                                               R
            are then either clipped or sutured with 2/0 PDS  II (polydiaxonone,   evacuated. This was managed by lavage and partial oversewing
            Johnson & Johnson). All patients receive 1 g of tranexamic acid   of the staple line. The patient was monitored on the high
            routinely at the beginning of the procedure. A leak test is performed
            routinely on all patients. Dual consultant operating occurred only   Table 1: Demographic and treatment details
            for mentoring purposes and in selected patients.    Total number                           38
               Ward-based care is provided for all patients unless preoperative
            anesthetic assessment recommends a higher level of care. Patients   Male: female          14 : 24
            are allowed to drink free fluids postoperatively. Patients are   Median age (range) years  51 (24–63)
            discharged on the first postoperative day if well, on a liquid diet   Median BMI at surgery, kg/m 2     42.9 (32.4–62.5)
            for 2 weeks. This is increased to a pureed diet for further 2 weeks.   Ethnicities  37 White British;
            Patients are reviewed initially after 1 week by phone followed by a                1 Black British/Caribbean
            clinical review in 6 weeks, 3 months, and 6 months. Excess weight   Comorbidities
                                                   2
            loss (%EWL) is calculated with a target BMI of 25 kg/m . Patients are   Diabetes           21
            then reviewed at 1 and 2 years prior to being discharged to their   Hypertension           13
            general practitioner if there are no ongoing concerns. Nutritional
            supplements and blood tests are in line with British Obesity &   Osteoarthritis            19
            Metabolic Surgery Society (BOMSS) recommendations. 9  Respiratory disease                    9
                                                                 Chronic kidney disease                  4
            COVID-19 Precautions and Deviations from Standard    Nonalcoholic fatty liver disease (NAFLD)    7
            of Care                                              Polycystic ovarian disease              2
            Preoperative                                         Obstructive sleep apnea               11
            We resumed bariatric surgery with patients who had been   Surgical approach
            categorized as urgent from our waiting list. All patients were   Laparoscopic              38
            requested to self-isolate for 14 days prior to surgery. Preoperative   Open                  0

                                                       World Journal of Laparoscopic Surgery, Volume 15 Issue 1 (January–April 2022)  27
   24   25   26   27   28   29   30   31   32   33   34